Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 16/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8619499 | 0.88 | CCKBR (0.55) | CCKBRHPGDEPHX2 | |
| SCHEMBL9436139 | 0.85 | CCKBR (0.53) | CCKBRHPGDEPHX2 | |
| SCHEMBL8638391 | 0.81 | CCKBR (0.64) | CCKBR | |
| SCHEMBL8616285 | 0.80 | CCKBR (0.46) | CCKBRHPGDEPHX2 | |
| SCHEMBL7044712 | 0.76 | HPGD (0.53) | CCKBRALDH1A1HSD17B10HPGD | |
| SCHEMBL8616731 | 0.76 | CCKBR (0.51) | CCKBRALDH1A1HSD17B10HPGD | |
| SCHEMBL8639633 | 0.75 | KMT2A (0.62) | CCKBRALDH1A1CASP7HSD17B10HPGD | |
| SCHEMBL8635136 | 0.74 | NPC1 (0.52) | CCKBRALDH1A1HSD17B10HPGD | |
| SCHEMBL8635124 | 0.74 | CCKBR (0.73) | CCKBR | |
| SCHEMBL4422153 | 0.73 | HPGD (0.74) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558104-B1 | 1,5-Benzodiazepine derivatives and their use in medicine | GLAXO WELLCOME SPA (IT) | 1998-07-29 | — | — | EP | disclosed |
| US-5637697-A | ANTAGONIST TO GASTRIN AND(OR) CHLOROCYSTOKININ | GLAXO SPA (IT) | 1997-06-10 | — | — | US | disclosed |
| US-5580895-A | GASTROINTESTINAL OR CENTRAL NERVOUS SYSTEM DISORDERS | GLAXO SPA (IT) | 1996-12-03 | — | — | US | disclosed |
| EP-0558104-A1 | 1,5-Benzodiazepine derivatives and their use in medicine | GLAXO S.p.A. (IT) | 1993-09-01 | — | — | EP | disclosed |